Report overview
Generic drugs are essential in oncology because some anticancer drugs are only available as generics.
This report contains market size and forecasts of Oncology Generic Injectable Drugs in global, including the following market information:
Global Oncology Generic Injectable Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Oncology Generic Injectable Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Oncology Generic Injectable Drugs companies in 2021 (%)
The global Oncology Generic Injectable Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Large Molecule Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Oncology Generic Injectable Drugs include Teva Pharmaceutical, Pfizer, AstraZeneca, Roche, Eli Lilly, GlaxoSmithKline, Novartis, Mylan and Natco Pharma. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Oncology Generic Injectable Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oncology Generic Injectable Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Oncology Generic Injectable Drugs Market Segment Percentages, by Type, 2021 (%)
Large Molecule Drugs
Small Molecule Drugs
Global Oncology Generic Injectable Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Oncology Generic Injectable Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Oncology Generic Injectable Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Oncology Generic Injectable Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oncology Generic Injectable Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Oncology Generic Injectable Drugs revenues share in global market, 2021 (%)
Key companies Oncology Generic Injectable Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Oncology Generic Injectable Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva Pharmaceutical
Pfizer
AstraZeneca
Roche
Eli Lilly
GlaxoSmithKline
Novartis
Mylan
Natco Pharma
